The Business Times
SUBSCRIBERS

Chugai investing S$476m more into S'pore facility

Funds will be used to boost Japanese drug maker's local employee base and antibody R&D pipeline

google-preferred-sourceAdd BT as a preferred source
Published Wed, Jan 28, 2015 · 09:50 PM

    Singapore

    JAPANESE drug maker Chugai Pharmaceutical on Wednesday announced that it will invest S$476 million from now until 2021 into its research institute in Singapore, Chugai Pharmabody Research (CPR).

    When CPR first set up its corporate laboratory here in 2012 to develop antibody drugs, it planned to pour about S$200 million into antibody research over the subsequent five years.

    EDB

    Copyright SPH Media. All rights reserved.

    Reuse this contentFeedback
    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More